Cognition Therapeutics Inc

NASDAQ:CGTX

1.95

+0.02 (+1.04%)

4:30:39 PM EDT: $1.94 -0.01 (-0.51%)

Cognition Therapeutics Inc Stock, NASDAQ:CGTX

2500 Westchester Avenue, Purchase, New York 10577

United States of America

Phone: +1.412.481.2210

Number of Employees: 28

http://www.cogrx.com

Description

Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as AlzheimerÃ¢â?¬â?¢s disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.